#sickle cell

New findings presented at ADLM 2026 show that immunoturbidimetric HbA1c assays can substantially underestimate values versus HPLC in sickle cell trait.

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids. The July 2026 expansion brings a CRISPR-based cure within reach earlier —...